Home › Funds › Citadel Advisors › ENTO

Citadel Advisors position in ENTO

ENTERO THERAPEUTICS INC

Latest position (Q2 2025)12.41K sh
Reported value held$4.97K
Portfolio Weight0.00%
First reportedQ3 2024
Last changeNew

Quarter by quarter

QuarterSharesValueChange
Q3 2024 10.05K $3.46K New
Q2 2025 12.41K $4.97K New
Q2 2025 12.41K $4.97K New

Dots on the line are colored by change type; missing quarters mean no position was reported.

Other funds holding ENTO

No other tracked fund reports a position in ENTO.

All ENTO fund holders →